Replimune (REPL) Cash & Current Investments (2018 - 2026)
Replimune's Cash & Current Investments came in at $195.33 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 51.6% from $403.34 million a year earlier and down 27.4% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Cash & Current Investments (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune's Cash & Current Investments was $268.89 million, down 44.4% from FY2025.
- Cash & Current Investments carries a five-year compound annual growth rate of -10.8% (FY2021 to FY2026).
- Going back by fiscal year, Cash & Current Investments was $483.8 million in FY2025 (+15.0%), $420.67 million in FY2024 (-27.9%), $583.39 million in FY2023 (+47.4%) and $395.66 million in FY2022 (-16.9%).
- The fiscal Q1 2027 figure represents the lowest quarterly Cash & Current Investments since fiscal Q4 2020.
- Year-over-year, Cash & Current Investments has declined for five consecutive quarters, with an average decline of 21.0% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in fiscal Q2 2022 (growth of 78.1%), and the weakest in fiscal Q1 2027 (a decline of 51.6%).
- Business Quant data shows REPL's Cash & Current Investments at $268.89 million (Q4 2026), $269.14 million (Q3 2026) and $323.64 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Replimune | 1.01 Bn | -50.09 Mn | - | 195.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 195.33 Mn |
| Mar 31, 2026 | 268.89 Mn |
| Dec 31, 2025 | 269.14 Mn |
| Sep 30, 2025 | 323.64 Mn |
| Jun 30, 2025 | 403.34 Mn |
| Mar 31, 2025 | 483.80 Mn |
| Dec 31, 2024 | 536.54 Mn |
| Sep 30, 2024 | 432.06 Mn |
| Jun 30, 2024 | 469.12 Mn |
| Mar 31, 2024 | 420.67 Mn |
| Dec 31, 2023 | 466.35 Mn |
| Sep 30, 2023 | 496.76 Mn |
| Jun 30, 2023 | 539.10 Mn |
| Mar 31, 2023 | 583.39 Mn |
| Dec 31, 2022 | 616.37 Mn |
| Sep 30, 2022 | 371.82 Mn |
| Jun 30, 2022 | 395.08 Mn |
| Mar 31, 2022 | 395.66 Mn |
| Dec 31, 2021 | 420.17 Mn |
| Sep 30, 2021 | 435.77 Mn |
API Access
Replimune Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();